Efficacy of XELOX plus Bevacizumab in Brain Metastasis from Rectal Cancer

Brain metastasis (BM) is rare in colorectal cancer (CRC) patients. Although BM from CRC is a late-stage phenomenon with an extremely poor prognosis, some subsets of patients would benefit from a multidisciplinary management strategy. The prognosis of patients with BM from CRC was associated with the...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Yoshida, Yoichiro, Hoshino, Seiichiro, Aisu, Naoya, Naito, Masayasu, Tanimura, Syu, Sasaki, Takamitsu, Takeno, Shinsuke, Yamashita, Yuichi
Format: Artigo
Jezik:Inglês
Izdano: S. Karger AG 2014
Teme:
Published online: February, 2014
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3975757/
https://ncbi.nlm.nih.gov/pubmed/24707258
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000360132
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items